Comparing Inpatient Costs of Heart Failure Admissions for Patients with Reduced and Preserved Ejection Fraction with or Without Type 2 Diabetes

Overview

Journal Cardiovasc Endocrinol Metab

Specialty Cardiology & Vascular Diseases

Date 2020 Feb 28

PMID 32104787

Citations 10

Authors

Natalia Olchanski

Amanda R Vest

Joshua T Cohen

David DeNofrio

Affiliations

Soon will be listed here.

Abstract

Methods: We created a retrospective cohort of acutely decompensated HF patients, using linked data from cost accounting systems and electronic medical records. We stratified patients by LVEF into reduced ejection fraction (HFrEF, LVEF ≤40%) and preserved ejection fraction (HFpEF, LVEF >40%) groups and by DM status at admission.

Results: Our population had 544 people: 285 HFrEF patients (43.5% with DM) and 259 HFpEF patients (43.6% with DM). Patients with HFrEF and DM had the longest hospital stay (5.10 ± 5.21 days). Patients with HFrEF and DM had the highest hospitalization cost ($11 576 ± 15 818). HFrEF and HFpEF patients with DM had the highest cost, and cost per day alive was highest for HFpEF patients with DM [$3153 (95% CI 2332, 4262)].

Conclusion: Overall cost was higher for patients with DM, whether or not they were admitted with acute HF due to HFrEF or HFpEF. Cost per day alive for patients with DM continued to exceed corresponding costs for patients without DM, with HFpEF patients with DM having the highest cost.

Citing Articles

Costs and Healthcare Utilization of Heart Disease by COVID-19 Diagnosis and Race and Ethnicity.

Lee J, Zhang Y, Pollack L, Luo F AJPM Focus. 2024; 4(1):100285.

PMID: 39628935 PMC: 11613426. DOI: 10.1016/j.focus.2024.100285.

Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand.

Kongmalai T, Prawjaeng J, Hadnorntun P, Leelahavarong P, Chaikledkaew U, Thakkinstian A Pharmacoecon Open. 2024; 9(1):69-81.

PMID: 39306816 PMC: 11717763. DOI: 10.1007/s41669-024-00526-2.

Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study.

Ong S, Low J, Yew W, Yen C, S K Abdul Kader M, Liew H Front Cardiovasc Med. 2022; 9:971592.

PMID: 36407426 PMC: 9666382. DOI: 10.3389/fcvm.2022.971592.

Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.

Escobar C, Palacios B, Varela L, Gutierrez M, Duong M, Chen H BMC Health Serv Res. 2022; 22(1):1241.

PMID: 36209120 PMC: 9547468. DOI: 10.1186/s12913-022-08614-x.

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy.

Benko J, Samos M, Bolek T, Pridavkova D, Jurica J, Pec M J Diabetes Res. 2022; 2022:3366109.

PMID: 35296100 PMC: 8920624. DOI: 10.1155/2022/3366109.

References

He J, Ogden L, Bazzano L, Vupputuri S, Loria C, Whelton P . Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001; 161(7):996-1002. DOI: 10.1001/archinte.161.7.996. View

Lam C, Donal E, Kraigher-Krainer E, Vasan R . Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2010; 13(1):18-28. PMC: 3003453. DOI: 10.1093/eurjhf/hfq121. View

Roger V, Weston S, Redfield M, Hellermann-Homan J, Killian J, Yawn B . Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 292(3):344-50. DOI: 10.1001/jama.292.3.344. View

Fang J, Mensah G, Croft J, Keenan N . Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008; 52(6):428-34. DOI: 10.1016/j.jacc.2008.03.061. View

. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018; 41(5):917-928. PMC: 5911784. DOI: 10.2337/dci18-0007. View

Owan T, Hodge D, Herges R, Jacobsen S, Roger V, Redfield M . Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355(3):251-9. DOI: 10.1056/NEJMoa052256. View

Kannel W, Hjortland M, CASTELLI W . Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974; 34(1):29-34. DOI: 10.1016/0002-9149(74)90089-7. View

Savarese G, Lund L . Global Public Health Burden of Heart Failure. Card Fail Rev. 2017; 3(1):7-11. PMC: 5494150. DOI: 10.15420/cfr.2016:25:2. View

Carr A, Kowey P, Devereux R, Brenner B, Dahlof B, Ibsen H . Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol. 2005; 96(11):1530-6. DOI: 10.1016/j.amjcard.2005.07.061. View

10.

Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K . Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18):1397-402. DOI: 10.1056/NEJMoa020265. View

11.

Peterson C, Xu L, Florence C, Grosse S, Annest J . Professional Fee Ratios for US Hospital Discharge Data. Med Care. 2015; 53(10):840-9. PMC: 4681390. DOI: 10.1097/MLR.0000000000000410. View

12.

Shindler D, Kostis J, Yusuf S, Quinones M, Pitt B, Stewart D . Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 1996; 77(11):1017-20. DOI: 10.1016/s0002-9149(97)89163-1. View

13.

Ozieh M, Bishu K, Dismuke C, Egede L . Trends in health care expenditure in U.S. adults with diabetes: 2002-2011. Diabetes Care. 2015; 38(10):1844-51. PMC: 4580605. DOI: 10.2337/dc15-0369. View

14.

Tiller D, Russ M, Greiser K, Nuding S, Ebelt H, Kluttig A . Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS One. 2013; 8(3):e59225. PMC: 3598658. DOI: 10.1371/journal.pone.0059225. View

15.

Whellan D, Zhao X, Hernandez A, Liang L, Peterson E, Bhatt D . Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines. J Card Fail. 2011; 17(8):649-56. DOI: 10.1016/j.cardfail.2011.04.005. View

16.

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

17.

Bhuiyan T, Maurer M . Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma. Curr Cardiovasc Risk Rep. 2011; 5(5):440-449. PMC: 3211140. DOI: 10.1007/s12170-011-0184-2. View

18.

Steinberg B, Zhao X, Heidenreich P, Peterson E, Bhatt D, Cannon C . Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012; 126(1):65-75. DOI: 10.1161/CIRCULATIONAHA.111.080770. View

19.

Krumholz H, Merrill A, Schone E, Schreiner G, Chen J, Bradley E . Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009; 2(5):407-13. DOI: 10.1161/CIRCOUTCOMES.109.883256. View

20.

Olchanski N, Vest A, Cohen J, Neumann P, DeNofrio D . Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions. Int J Cardiol. 2018; 261:103-108. DOI: 10.1016/j.ijcard.2018.03.024. View